183 related articles for article (PubMed ID: 37343519)
61. "Veozah (Fezolinetant): A Promising Non-Hormonal Treatment for Vasomotor Symptoms in Menopause".
Shaukat A; Mujeeb A; Shahnoor S; Nasser N; Khan AM
Health Sci Rep; 2023 Oct; 6(10):e1610. PubMed ID: 37808928
[TBL] [Abstract][Full Text] [Related]
62. Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms.
Speroff L
Obstet Gynecol; 2003 Oct; 102(4):823-34. PubMed ID: 14551014
[TBL] [Abstract][Full Text] [Related]
63. Estradiol/progesterone (Bijuva) for menopausal vasomotor symptoms.
Med Lett Drugs Ther; 2019 Jul; 61(1575):99-101. PubMed ID: 31381541
[No Abstract] [Full Text] [Related]
64. Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment.
Rapkin AJ
Am J Obstet Gynecol; 2007 Feb; 196(2):97-106. PubMed ID: 17306645
[TBL] [Abstract][Full Text] [Related]
65. Equol improves menopausal symptoms in Japanese women.
Aso T
J Nutr; 2010 Jul; 140(7):1386S-9S. PubMed ID: 20484552
[TBL] [Abstract][Full Text] [Related]
66. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
[TBL] [Abstract][Full Text] [Related]
67. Clinical investigation of RAD1901, a novel estrogen receptor ligand, for the treatment of postmenopausal vasomotor symptoms: a phase 2 randomized, placebo-controlled, double-blind, dose-ranging, proof-of-concept trial.
Hattersley G; Harris AG; Simon JA; Constantine GD
Menopause; 2017 Jan; 24(1):92-99. PubMed ID: 27575546
[TBL] [Abstract][Full Text] [Related]
68. Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: a randomized controlled trial.
LaCroix AZ; Freeman EW; Larson J; Carpenter JS; Joffe H; Reed SD; Newton KM; Seguin RA; Sternfeld B; Cohen L; Ensrud KE
Maturitas; 2012 Dec; 73(4):361-8. PubMed ID: 23031421
[TBL] [Abstract][Full Text] [Related]
69. A Nonhormonal Selective NK3R Antagonist for Moderate to Severe Vasomotor Symptoms in Menopause.
O'Malley PA
Clin Nurse Spec; 2023 Nov-Dec 01; 37(6):259-261. PubMed ID: 37870510
[No Abstract] [Full Text] [Related]
70. Menopause is more than Hot Flashes: What is Missing in Homeopathic Research? A Narrative Review.
Macías-Cortés E
Homeopathy; 2022 May; 111(2):79-96. PubMed ID: 34634835
[TBL] [Abstract][Full Text] [Related]
71. A randomized, double-blind, placebo-controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women.
Haines CJ; Lam PM; Chung TK; Cheng KF; Leung PC
Climacteric; 2008 Jun; 11(3):244-51. PubMed ID: 18568789
[TBL] [Abstract][Full Text] [Related]
72. Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms.
Stearns V
Treat Endocrinol; 2006; 5(2):83-7. PubMed ID: 16542048
[TBL] [Abstract][Full Text] [Related]
73. Evaluating the evidence for over-the-counter alternatives for relief of hot flashes in menopausal women.
Kelley KW; Carroll DG
J Am Pharm Assoc (2003); 2010; 50(5):e106-15. PubMed ID: 20833608
[TBL] [Abstract][Full Text] [Related]
74. A pilot study to examine a combination botanical for the treatment of menopausal symptoms.
Smolinski D; Wollner D; Orlowski J; Curcio J; Nevels J; Kim LS
J Altern Complement Med; 2005 Jun; 11(3):483-9. PubMed ID: 15992234
[TBL] [Abstract][Full Text] [Related]
75. 'Feeling hot, hot, hot': is there a role for exercise in the management of vasomotor and other menopausal symptoms?
Daley AJ; Stokes-Lampard H; MacArthur C
J Fam Plann Reprod Health Care; 2007 Jul; 33(3):143-5. PubMed ID: 17609065
[No Abstract] [Full Text] [Related]
76. Deal watch: Neurokinin 3 receptor antagonist revival heats up with Astellas acquisition.
Cully M
Nat Rev Drug Discov; 2017 May; 16(6):377. PubMed ID: 28559557
[No Abstract] [Full Text] [Related]
77. Estradiol gel: review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women.
Naunton M; Al Hadithy AF; Brouwers JR; Archer DF
Menopause; 2006; 13(3):517-27. PubMed ID: 16735950
[TBL] [Abstract][Full Text] [Related]
78. Finished herbal product as an alternative treatment for menopausal symptoms in climacteric women.
Lai JN; Hwang JS; Chen HJ; Wang JD
J Altern Complement Med; 2005 Dec; 11(6):1075-84. PubMed ID: 16398600
[TBL] [Abstract][Full Text] [Related]
79. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
Utian WH
Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
[TBL] [Abstract][Full Text] [Related]
80. Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial.
Brunner RL; Aragaki A; Barnabei V; Cochrane BB; Gass M; Hendrix S; Lane D; Ockene J; Woods NF; Yasmeen S; Stefanick M
Menopause; 2010; 17(5):946-54. PubMed ID: 20505547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
